Substrate

Bibliography

Biblio print

Tree Display

AceDB Schema

XML Display

Feedback

Substrate Report for: Remdesivir

Remdesivir is a prodrug of an adenosine triphosphate (ATP) analog, with potential antiviral activity against a variety of RNA viruses. Substrate of CES1 and inhibitor of CES2. Remdesivir was initially developed by Gilead Sciences as an anti-Ebola agent.Clinical trials were initiated and conducted to evaluate Remdesivir safety and efficacy in COVID-19 patients



General
Type: Pro-Drug, Drug, Not A/B H target, Propionate
Chemical_Nomenclature: 2-ethylbutyl (2S)-2-[[[(2R,3S,4R,5R)-5-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-5-cyano-3,4-dihydroxyoxolan-2-yl]methoxy-phenoxyphosphoryl]amino]propanoate
Canonical SMILES: CCC(CC)COC(=O)C(C)NP(=O)(OCC1C(C(C(O1)(C#N)C2=CC=C3N2N=CN=C3N)O)O)OC4=CC=CC=C4
InChI: InChI=1S/C27H35N6O8P/c1-4-18(5-2)13-38-26(36)17(3)32-42(37,41-19-9-7-6-8-10-19)39-14-21-23(34)24(35)27(15-28,40-21)22-12-11-20-25(29)30-16-31-33(20)22/h6-12,16-18,21,23-24,34-35H,4-5,13-14H2,1-3H3,(H,32,37)(H2,29,30,31)/t17-,21+,23+,24+,27-,42-/m0/s1
InChIKey: RWWYLEGWBNMMLJ-YSOARWBDSA-N
Other name(s): 3QKI37EEHE ; GS 5734 ; GS-5734 ; CHEMBL4065616 ; SCHEMBL17712225 ; CHEBI:145994
MW: 602.6
Formula: C27H35N6O8P
CAS_number: 1809249-37-3
PubChem: 121304016
IUPHAR:
Wikipedia:

Target families
Remdesivir ligand of proteins in family: Carb_B_Chordata, Carboxypeptidase_S10
No structure

Protein target

References
Search PubMed for references concerning: Remdesivir

3 more
    Title: Key Metabolic Enzymes Involved in Remdesivir Activation in Human Lung Cells
    Li R, Liclican A, Xu Y, Pitts J, Niu C, Zhang J, Kim C, Zhao X, Soohoo D and Feng JY <14 more author(s)>
    Ref: Antimicrobial Agents & Chemotherapy, :AAC0060221, 2021 : PubMed

            

    Title: Remdesivir potently inhibits carboxylesterase-2 through covalent modifications: signifying strong drug-drug interactions
    Shen Y, Eades W, Yan B
    Ref: Fundamental & Clinical Toxicology, 35:432, 2021 : PubMed

            

    Title: Coronavirus Susceptibility to the Antiviral Remdesivir (GS-5734) Is Mediated by the Viral Polymerase and the Proofreading Exoribonuclease
    Agostini ML, Andres EL, Sims AC, Graham RL, Sheahan TP, Lu X, Smith EC, Case JB, Feng JY and Denison MR <7 more author(s)>
    Ref: MBio, 9:, 2018 : PubMed